ipilimumab,nivolumab
bms
['nivo', 'biomarker', 'ipilimumab', 'gastric', 'nivolumab']
dr. yelena janjigian ( ) will present biomarker analysis results of nivolumab plus ipilimumab vs. chemotherapy as first-line treatment for advanced #gastriccancer at #aacr23. the session will take place at 2:30 p.m. et in the chapin theater. 
One of the world’s leading comprehensive cancer centers. To make an appointment: (833) 390-0294